Allspring Global Investments’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.01M	Sell	214,572 -293,395	-58%	-$11M	0.02%	721
2025 Q4	$19.4M	Buy	507,967 +268,155	+112%	+$21.1M	0.03%	549
2025 Q3	$20.2M	Buy	239,812 +25,206	+12%	+$1.82M	0.03%	544
2025 Q2	$14.9M	Sell	214,606 -13,406	-6%	-$972K	0.02%	599
2025 Q1	$21M	Buy	228,012 +16,546	+8%	+$1.01M	0.04%	504
2024 Q4	$10.6M	Sell	211,466 -39,602	-16%	-$2.08M	0.02%	742
2024 Q3	$11.6M	Buy	251,068 +123,720	+97%	+$4.4M	0.02%	719
2024 Q2	$4.14M	Buy	127,348 +541	+0.4%	+$14.8K	0.01%	996
2024 Q1	$3.19M	Buy	126,807 +58,468	+86%	+$1.38M	0.01%	1066
2023 Q4	$2.22M	Sell	68,339 -15,358	-18%	-$422K	﹤0.01%	1152
2023 Q3	$2.28M	Buy	83,697 +65,148	+351%	+$1.89M	﹤0.01%	1158
2023 Q2	$413K	Sell	18,549 -96,859	-84%	-$2.23M	﹤0.01%	1607
2023 Q1	$2.5M	Sell	115,408 -25,120	-18%	-$551K	﹤0.01%	1181
2022 Q4	$2.85M	Buy	140,528 +67,462	+92%	+$1.69M	﹤0.01%	1142
2022 Q3	$1.87M	Buy	73,066 +57,775	+378%	+$1.55M	﹤0.01%	1250
2022 Q2	$363K	Sell	15,291 -71,969	-82%	-$1.57M	﹤0.01%	1659
2022 Q1	$1.97M	Sell	87,260 -2,815	-3%	-$59.9K	﹤0.01%	1511
2021 Q4	$1.78M	Buy	+90,075	New	+$1.83M	﹤0.01%	1603